Joseph Payne is President and Chief Executive Officer, Director of Arcturus Therapeutics Holdings Inc. (ARCT). The company reported total compensation of $1,691,000 for fiscal year 2025.
| Salary | $750,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $941,000 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $1,691,000 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Arcturus Therapeutics Holdings Inc. filed April 24, 2026, accession 0001193805-26-000507.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Joseph Payne this page | President and Chief Executive Officer, Director | $1,691,000 |
| Andy Sassine | Former Chief Financial Officer | $1,181,500 |
| Padmanabh Chivukula | Chief Scientific Officer, Chief Operating Officer | $862,000 |
| Lance Kurata | Chief Legal Officer | $830,000 |
| Joe Roberts | Interim Principal Financial and Accounting Officer; Controller | $273,580 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Arcturus Therapeutics Holdings Inc. compensation brief.
Joseph Payne's compensation sits inside Arcturus Therapeutics Holdings Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Arcturus Therapeutics Holdings Inc. (ARCT) compensation brief